Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2018-1673
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM WebSphere Portal 7.0, 8.0, 8.5, and 9.0 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 145108.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM WebSphere Portal 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM WebSphere Portal是美国IBM公司的一套企业门户软件。该软件能够创建一个联接企业内部和外部的平台,可让员工、客户和供应商等通过该平台访问企业内部数据。 IBM WebSphere Portal中存在跨站脚本漏洞。远程攻击者可利用该漏洞向Web UI中注入任意的JavaScript代码。以下版本受到影响:IBM WebSphere Portal 7.0版本,8.0版本,8.5版本,9.0版本。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMWebSphere Portal 7.0 -
II. Public POCs for CVE-2018-1673
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2018-1673
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2018-1673

No comments yet


Leave a comment